Brief: Medicamen Biotech Says US FDA Approved Sterile Injectable Oncology Formulation Facility At Haridwar
25/10/2024 09:20
Oct 25 (Reuters) - Medicamen Biotech Ltd MEBI.NS :
* US FDA APPROVED STERILE INJECTABLE ONCOLOGY FORMULATION
FACILITY
AT HARIDWAR
Source text for Eikon: ID:nBSE9QTBJ4
Further company coverage: MEBI.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Medicamen Biotech
See all newsBrief: Medicamen Biotech Recommends Final Dividend Of 1 Rupee Per Share For FY Ended March 31, 2026
Brief: Medicamen Biotech Gets EU Approval For Registration Of “Paracetamol” From Denmark With XGX Pharma
India's Medicamen Biotech gains on US FDA nod for blood cancer drug
Brief: Medicamen Biotech Approves Allotment Of Shares, Warrants
India's Medicamen Biotech rises after deal with Denmark's XGX Pharma